AAAAAA
Results:
1-14
|
Results: 14
Authors:
Witherington, J
Bordas, V
Cooper, DG
Forbes, IT
Gribble, AD
Ife, RJ
Berkhout, T
Gohil, J
Groot, PHE
Citation: J. Witherington et al., Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists, BIOORG MED, 11(16), 2001, pp. 2177-2180
Authors:
Van Eck, M
Van Dijk, KW
Herijgers, N
Hofker, MH
Groot, PHE
Van Berkel, TJC
Citation: M. Van Eck et al., Essential role for the (hepatic) LDL receptor in macrophage apolipoproteinE-induced reduction in serum cholesterol levels and atherosclerosis, ATHEROSCLER, 154(1), 2001, pp. 103-112
Authors:
Van Eck, M
Zimmermann, R
Groot, PHE
Zechner, R
Van Berkel, TJC
Citation: M. Van Eck et al., Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis, ART THROM V, 20(9), 2000, pp. E53-E62
Authors:
Herijgers, N
Van Eck, M
Groot, PHE
Hoogerbrugge, PM
Van Berkel, TJC
Citation: N. Herijgers et al., Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57B1/6 mice, ART THROM V, 20(8), 2000, pp. 1961-1967
Authors:
Van Eck, M
De Winther, MPJ
Herijgers, N
Havekes, LM
Hofker, MH
Groot, PHE
Van Berkel, TJC
Citation: M. Van Eck et al., Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice, ART THROM V, 20(12), 2000, pp. 2600-2606
Authors:
Van Eck, M
Herijgers, N
Van Dijk, KW
Havekes, LM
Hofker, MH
Groot, PHE
Van Berkel, TJC
Citation: M. Van Eck et al., Effect of macrophage-derived mouse apoE, human apoE3-Leiden, and human apoE2 (Arg158 -> Cys) on cholesterol levels and atherosclerosis in apoE-deficient mice, ART THROM V, 20(1), 2000, pp. 119-127
Authors:
Rayner, K
Van Eersel, S
Groot, PHE
Reape, TJ
Citation: K. Rayner et al., Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atheroscleroticlesions of the ApoE knockout mouse, J VASC RES, 37(2), 2000, pp. 93-102
Authors:
Forbes, IT
Cooper, DG
Dodds, EK
Hickey, DMB
Ife, RJ
Meeson, M
Stockley, M
Berkhout, TA
Gohil, J
Groot, PHE
Moores, K
Citation: It. Forbes et al., CCR2B receptor antagonists: Conversion of a weak HTS hit to a potent lead compound, BIOORG MED, 10(16), 2000, pp. 1803-1806
Authors:
Grimsditch, DC
Penfold, S
Latcham, J
Vidgeon-Hart, M
Groot, PHE
Benson, GM
Citation: Dc. Grimsditch et al., C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile, ATHEROSCLER, 151(2), 2000, pp. 389-397
Authors:
Van Eck, M
Herijgers, N
Vidgeon-Hart, M
Pearce, NJ
Hoogerbrugge, PM
Groot, PHE
Van Berkel, TJC
Citation: M. Van Eck et al., Accelerated atherosclerosis in C57B1/6 mice transplanted with ApoE-deficient bone marrow, ATHEROSCLER, 150(1), 2000, pp. 71-80
Authors:
Berkhout, TA
Gohil, J
Gonzalez, P
Nicols, CL
Moores, KE
Macphee, CH
White, JR
Groot, PHE
Citation: Ta. Berkhout et al., Selective binding of the truncated form of the chemokine CK beta 8 (25-99)to CC chemokine receptor 1 (CCR1), BIOCH PHARM, 59(5), 2000, pp. 591-596
Authors:
Reape, TJ
Groot, PHE
Citation: Tj. Reape et Phe. Groot, Chemokines and atherosclerosis, ATHEROSCLER, 147(2), 1999, pp. 213-225
Authors:
Reape, TJ
Rayner, K
Manning, CD
Gee, AN
Barnette, MS
Burnand, KG
Groot, PHE
Citation: Tj. Reape et al., Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques, AM J PATH, 154(2), 1999, pp. 365-374
Authors:
Benson, GM
Schiffelers, R
Nicols, C
Latcham, J
Vidgeon-Hart, M
Toseland, CDN
Suckling, KE
Groot, PHE
Citation: Gm. Benson et al., Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice, ATHEROSCLER, 141(2), 1998, pp. 237-247
Risultati:
1-14
|